explore -WSS

explore

author：hotspot 2025-09-03 12:09:57 - browse：917

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday.

The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

Depemokimab hit its primary endpoints in the trials, reducing asthma attacks over a year’s time frame. The company didn’t disclose exact details from the SWIFT-1 and SWIFT-2 trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Richard Slayman had a rejection episode of his pig kidney before leaving hospital

entertainment

focus

WSS

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

CDC panel: People 65 and older should get a Covid spring booster shot

Neuroscience renaissance leads to new crop of psychiatric drugs

Readout Newsletter: Beam, Prozac, "TechBio" and more

U.S. death rates show how politics are affecting public health

New research sheds light on how often breast cancer is overdiagnosed

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Hollywood unions extend contract negotiations for actors

New research sheds light on how often breast cancer is overdiagnosed

BioMarin wins approval for gene therapy to treat hemophilia A

Color Health wants to make cancer screenings convenient

Hollywood unions extend contract negotiations for actors

Neuroscience renaissance leads to new crop of psychiatric drugs

After affirmative action ruling, medical educators look to 'holistic review'

Neuroscience renaissance leads to new crop of psychiatric drugs

Continuity nursing helped my family in our darkest PICU moments

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

focus

Lawsuit challenges CMS nursing home minimum staffing rule

Virtual repurposing can help discover new uses for existing drugs

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Stroke rates rising, especially in working

Hospitals need to get ahead of regulations on climate change

Medicare isn't yet testing food as medicine

Wikipedia

entertainment

focus

leisure time